Trobix Bio
About
Trobix Bio is developing orally administered precision oncology therapeutics by leveraging its TBX™ technology platform. This platform utilizes CRISPR, phage, and synthetic biology to precisely re-program specific bacterial activities within the human microbiome.
Key facts
At-a-glance profile data
- Website
- trobix.bio
- Headquarters
- San Diego, United States
- Founded
- 2019
- Employees
- 13
- Total funding
- $3M (Series A)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 30 Mar 2023 | Series A | $3M | Chartered Group |
Tech stack
Detected on trobix.bio, last scanned 12 Sept 2026. Run your own scan
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has Trobix Bio raised?
Trobix Bio has raised a total of $3M in funding. The most recent round on record is Series A.
How many employees does Trobix Bio have?
Trobix Bio has approximately 13 people on record.